Miromatrix Medical is among the emerging biotech companies “Making BIO History” at the 2018 BIO International Convention, June 4-7 in Boston, Mass. CEO Jeff Ross, Ph.D. will present on The Future of Bioengineered Organs and Miromatrix’ vision to eliminate the organ transplant waiting list on Wednesday, June 6 at 11 a.m. in Theater 1. “It is an honor to have Miromatrix selected to present at BIO and share our ground-breaking technology with investors and companies in the biotech, pharma, and medical device space," said Ross.
Sponsored by the Biotechnology Innovation Organization (BIO), the convention is one of the largest gatherings representing over 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. It provides biotech organizations the opportunity to gather together, learn from one another and advocate for the global biotech industry.
Check out Dr. Ross' overview presentation in the link below.